0.00Open0.07Pre Close0 Volume109 Open Interest60.00Strike Price0.00Turnover5284.57%IV23.24%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-6DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.0245Delta0.0079Gamma1115.29Leverage Ratio-148.3409Theta0.0000Rho-27.36Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet